Lopez-Quintero C, Roth KB, Eaton WW, Wu L, Cottler LB, Bruce M, et al. Mortality among heroin users and users of other internationally regulated drugs: a 27-year follow-up of users in the Epidemiologic Catchment Area Program household samples. Drug Alcohol Depend. 2015;156:104–11. https://doi.org/10.1016/j.drugalcdep.2015.08.030.
Article
PubMed
PubMed Central
Google Scholar
van Amsterdam J, Nutt D, Phillips L, van den Brink W. European rating of drug harms. J Psychopharmacol. 2015;29:655–60. https://doi.org/10.1177/0269881115581980.
Article
PubMed
Google Scholar
UNODC. World Drug Report Executive summary. Conclusions and Policy Implications. Vienna: United Nations Office on Drugs and Crime; 2018.
Google Scholar
Larney S, Peacock A, Leung J, Colledge S, Hickman M, Vickerman P, et al. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review. Lancet Glob Heal. 2017;5:1–13. https://doi.org/10.1016/S2214-109X(17)30373-X.
Article
Google Scholar
UNAIDS. Health, rights and drugs. Harm reduction, decriminalization and zero discrimination for people who use drugs. 2019.
Stahl S. Stahl’s essential pscyhopharmacology. Cambridge: Cambridge University Press; 2013.
Google Scholar
Somer E, Avni R. Dissociative phenomena among recovering heroin users and their relationship to duration of abstinence. J Soc Work Pract Addict. 2003;3:25–38. https://doi.org/10.1300/J160v03n01_03.
Article
Google Scholar
Valentine K, Fraser S. Trauma damage and pleasure: Rethinking problematic drug use. Int J Drug Policy. 2008;19:410–6.
Article
PubMed
Google Scholar
Schindler A, Thomasius R, Petersen K, Sack P-M. Heroin as an attachment substitute? Differences in attachment representations between opioid, ecstasy and cannabis abusers. Attach Hum Dev. 2009;11:307–30. https://doi.org/10.1080/14616730902815009.
Article
PubMed
Google Scholar
Kaiko RF, Wallenstein SL, Rogers AG, Grabinski PY, Houde RW. Analgesic and mood effects of heroin and morphine in cancer patients with postoperative pain. N Engl J Med. 1981;304:1501–5. https://doi.org/10.1056/NEJM198106183042501.
Article
CAS
PubMed
Google Scholar
WHO. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. Geneva: World Health Organization; 2009.
Google Scholar
Beg M, Strathdee SA, Kazatchkine M. State of the Art Science addressing Injecting Drug Use, HIV and Harm Reduction. Int J Drug Policy. 2014. https://doi.org/10.1016/j.drugpo.2014.11.008.
Article
PubMed
Google Scholar
World Health Organization, United Nations Office on Drugs and Crime, Joint United Nations Programme on HIV/AIDS. Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention. Position paper. 2004; 1–33.
Caplehorn JR, Dalton MS, Haldar F, Petrenas AM, Nisbet JG. Methadone maintenance and addicts’ risk of fatal heroin overdose. Subst Use Misuse. 1996;31:177–96.
Article
CAS
PubMed
Google Scholar
Wilson DP, Donald B, Shattock AJ, Wilson D, Fraser-Hurt N. The cost-effectiveness of harm reduction. Int J Drug Policy. 2015;26:S5–11. https://doi.org/10.1016/j.drugpo.2014.11.007.
Article
PubMed
Google Scholar
Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, Taylor RJ, et al. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess. 2007;11:1–171.
CAS
PubMed
Google Scholar
Kourounis G, Richards BDW, Kyprianou E, Symeonidou E, Malliori M-M, Samartzis L. Opioid substitution therapy: lowering the treatment thresholds. Drug Alcohol Depend. 2016;161:1–8. https://doi.org/10.1016/j.drugalcdep.2015.12.021.
Article
PubMed
Google Scholar
Christie TKS, Murugesan A, Manzer D, Shaughnessey MVO, Webster D. Evaluation of a low-threshold / high-tolerance methadone maintenance treatment clinic in saint john, new Brunswick, Canada: 1 year retention rate and illicit drug use. J Addict. 2013;13:1–5. https://doi.org/10.1155/2013/753409.
Article
Google Scholar
Torrens M, Castillo C, Pérez-Solá V. Retention in a low-threshold methadone maintenance program. Drug Alcohol Depend. 1996;41:55–9. https://doi.org/10.1016/0376-8716(96)01230-6.
Article
CAS
PubMed
Google Scholar
Harris J, McElrath K. Methadone as Social Control. Qual Health Res. 2012;22:810–24.
Article
PubMed
Google Scholar
Gourlay J, Ricciardelli L, Ridge D. Users’ experiences of heroin and methadone treatment. Subst Use Misuse. 2005;40:1875–82.
Article
PubMed
Google Scholar
Scheibe A, Marks M, Shelly S, Gerardy T, Domingo A, Hugo J. Developing an advocacy agenda for increasing access to opioid substitution therapy as part of comprehensive services for people who use drugs in South Africa. S Afr Med J. 2018;108:800–2.
Article
CAS
PubMed
Google Scholar
United Nations Office on Drugs and Crime. World Drug Report 2015. Vienna: United Nations Office on Drugs and Crime; 2015.
Book
Google Scholar
United Nations Office on Drugs and Crime. UNODC 2018 Prevalence of drug use in the general population–national data. Vienna: United Nations Office on Drugs and Crime; 2018.
Google Scholar
Statistics South Africa. Mid-year population estimates 2018. Statistical release P0302. Pretoria: Statistics South Africa; 2018.
Google Scholar
Dada S, Harker Burnhams N, Erasmus J, Parry C, Bhana A, Kitshoff D, et al. Monitoring alcohol, tobacco and other drug use trends in South Africa. Res Brief. 2017;20:1–9.
Google Scholar
Howell S, Harker-Burnhams N, Townsend L, Shaw M. The wrong type of decline: fluctuations in price and value of illegal substances in Cape Town. SA Crime Q. 2015;54(1):43–544.
Article
Google Scholar
Weich L. Defeating the dragon–can we afford not to treat patients with heroin dependence? S Afr J Psychiatry. 2010;16:75–9.
Google Scholar
Michie G, Hoosain S, Macharia M, Weich L. Report on the first government-funded opioid substitution programme for heroin users in the Western Cape Province, South Africa. S Afr Med J. 2017;107:539–42.
Article
CAS
PubMed
Google Scholar
World Health Organization. Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations. Geneva: World Health Organization; 2016.
Google Scholar
Scheibe A, Shelly S, Versfeld A, Howell S, Marks M. Safe treatment and treatment of safety: call for a harm-reduction approach to drug-use disorders in South Africa. S Afr Health Rev. 2017;20:197–204.
Google Scholar
van Dyk J. Durban cuts city’s only needle exchange programme. Bhekisisa. 2018. https://bhekisisa.org/article/2018-05-30-00-durban-cuts-citys-only-needle-exchange-programme/. Accessed 30 Nov 2019.
Scheibe A, Matima R, Schneider A, Basson R, Ngcebetsha S, Padayachee K, et al. Still left behind: harm reduction coverage and HIV treatment cascades for people who inject drugs in South Africa. In: 10th IAS Conference on HIV Science. Mexico; 2019.
South African National Department of Health. Standard treatment guidelines and essential medicines list for South Africa. Hospital level. 3rd ed. Pretoria: Department of Health; 2012.
Google Scholar
International Narcotics Control Board. Narcotic drugs 2018. Estimated requirements for 2019. Statistics for 2017. 2018; 1–494. https://www.incb.org/documents/Narcotic-Drugs/Technical-Publications/2018/INCB-Narcotics_Drugs_Technical_Publication_2018.pdf.
Weich L. Defeating the dragon—can we afford not to treat patients with heroin dependence? S Afr J Psychiatry. 2010. https://doi.org/10.4102/sajpsychiatry.v16i3.260.
Article
Google Scholar
National Department of Health. Standard treatment guidelines and essential medicines list for South Africa: primary healthcare level. 2018th ed. Pretoria: South African National Department of Health; 2018.
Google Scholar
Harm Reduction International. The Global state of harm reduction 2018. 6th ed. London: Harm Reduction International; 2018.
Google Scholar
World Health Organization. The alcohol smoking and substance involvement screening test. Geneva: World Health Organization; 2010.
Google Scholar
Weich L, Nowbath H, Flegar S, Mahomedy Z, Ramjee H, Hitzeroth V, et al. South African guidelines for the management of opioid dependence. Updated 2013. 2013.
Weich L, Perkel C, van Zyl N, Rataemane P, Naidoo L, Nowbath H, et al. South African guidelines for the management of opioid dependence. S Afr Addict Med Soc. 2013;100:1–18.
Google Scholar
Quality Metric Incorporated. User’s manual for the SF-12v2 Health survey. 3rd ed. Quality Metric Incorporated: Lincoln; 2012.
Google Scholar
Veilleux JC, Colvin PJ, Anderson J, York C, Heinz AJ. A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction. Clin Psychol Rev. 2010;30:155–66.
Article
PubMed
Google Scholar
Bell J. Pharmacological maintenance treatments of opiate addiction. Br J Clin Pharmacol. 2014;77:253–63.
Article
CAS
PubMed
PubMed Central
Google Scholar
Timko C, Schultz NR, Cucciare MA, Vittorio L, Garrison-Diehn C. Retention in medication-assisted treatment for opiate dependence: a systematic review. J Addict Dis. 2016;35:22–35. https://doi.org/10.1080/10550887.2016.1100960.
Article
PubMed
Google Scholar
Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. Lancet. 1999;353:221–6. https://doi.org/10.1016/S0140-6736(98)05356-2.
Article
CAS
PubMed
Google Scholar
Feelemyer J, Des Jarlais D, Arasteh K, Abdul-Quader AS, Hagan H. Retention of participants in medication-assisted programs in low- and middle-income countries: an international systematic review. Addiction. 2014;109:20–322. https://doi.org/10.1111/add.12303.
Article
PubMed
Google Scholar
Connery HS. Medication-assisted treatment of opioid use disorder. Harv Rev Psychiatry. 2015;23:63–75. https://doi.org/10.1097/HRP.0000000000000075.
Article
PubMed
Google Scholar
Akindipe T, Abiodun L, Adebajo S, Lawal R, Rataemane S. From addiction to infection: managing drug abuse in the context of HIV/AIDS in Africa. Afr J Reprod Health. 2014;18(3):47–544.
PubMed
Google Scholar
Brorson HH, Ajo Arnevik E, Rand-Hendriksen K, Duckert F. Drop-out from addiction treatment: a systematic review of risk factors. Clin Psychol Rev. 2013;33:1010–24. https://doi.org/10.1016/j.cpr.2013.07.007.
Article
PubMed
Google Scholar
Yang F, Lin P, Li Y, He Q, Long Q, Fu X, et al. Predictors of retention in community-based methadone maintenance treatment program in Pearl River Delta. China Harm Reduct J. 2013;10:3. https://doi.org/10.1186/1477-7517-10-3.
Article
PubMed
Google Scholar
Walley AY, Cheng DM, Pierce CE, Chen C, Filippell T, Samet JH, et al. Methadone dose, take home status, and hospital admission among methadone maintenance patients. J Addict Med. 2012;6:186–90.
Article
CAS
PubMed
PubMed Central
Google Scholar
Garcia-Portilla MP, Bobes-Bascaran MT, Bascaran MT, Saiz PA, Bobes J. Long term outcomes of pharmacological treatments for opioid dependence: does methadone still lead the pack? Br J Clin Pharmacol. 2014;77:272–84. https://doi.org/10.1111/bcp.12031.
Article
CAS
PubMed
PubMed Central
Google Scholar
Villafranca SW, McKellar JD, Trafton JA, Humphreys K. Predictors of retention in methadone programs: a signal detection analysis. Drug Alcohol Depend. 2006;83:218–24.
Article
PubMed
Google Scholar
Lo A, Kerr T, Hayashi K, Milloy MJ, Nosova E, Liu Y, et al. Factors associated with methadone maintenance therapy discontinuation among people who inject drugs. J Subst Abuse Treat. 2018;94:41–6. https://doi.org/10.1016/j.jsat.2018.08.009.
Article
PubMed
PubMed Central
Google Scholar
Smolka M, Schmidt LG. The influence of heroin dose and route of administration on the severity of the opiate withdrawal syndrome. Addiction. 1999;94:1191–8.
Article
CAS
PubMed
Google Scholar
Shen L, Assanangkornchai S, Liu W, Cai L, Li F, Tang S, et al. Influence of social network on drug use among clients of methadone maintenance treatment centers in Kunming China. PLoS ONE. 2018;13:e0200105. https://doi.org/10.1371/journal.pone.0200105.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kwan TH, Wong NS, Lee SS. Participation dynamics of a cohort of drug users in a low-threshold methadone treatment programme. Harm Reduct J. 2015;12:30. https://doi.org/10.1186/s12954-015-0072-z.
Article
PubMed
PubMed Central
Google Scholar
Amato L, Minozzi S, Davoli M, Vecchi S. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev. 2011. https://doi.org/10.1002/14651858.CD004147.pub4.
Article
PubMed
PubMed Central
Google Scholar
Amato L, Davoli M, Minozzi S, Ferroni E, Ali R, Ferri M. Methadone at tapered doses for the management of opioid withdrawal. Cochrane database Syst Rev. 2013;2:CD003409.
Google Scholar
Lingford-Hughes AR, Welch S, Peters L, Nutt DJ, et al. BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. J Psychopharmacol. 2012;26:899–952.
Article
CAS
PubMed
Google Scholar
Van Den Brink WW, Haasen C. Evidenced-based treatment of opioid-dependent patients. Can J Psychiatry-Revue Can Psychiatr. 2006;51:635–46.
Article
Google Scholar
Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. A Meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry. 2008;165:179–87. https://doi.org/10.1176/appi.ajp.2007.06111851.
Article
PubMed
Google Scholar
Mattick RP, Breen C, Kimber J, Davoli M, Richard PM, Breen C, et al. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;2:CD002207.
Google Scholar
DA W, MG W, BE H, SM H. Factors associated with lapses to heroin use during methadone maintenance. Drug Alcohol Depend. 1998;52:183–92. https://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed4&NEWS=N&AN=1998393995.
Franklyn AM, Eibl JK, Gauthier GJ, Pellegrini D, Lightfoot NE, Marsh DC. The impact of cocaine use in patients enrolled in opioid agonist therapy in Ontario, Canada. Int J Drug Policy. 2017;48:1–8. https://doi.org/10.1016/j.drugpo.2017.05.044.
Article
PubMed
Google Scholar
Epstein DH, Preston KL. Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against. [comment] [erratum appears in Addiction. 2003 Apr 98(4):538]. Addiction. 2003;98:269–79.
Article
CAS
PubMed
PubMed Central
Google Scholar
Socías ME, Wood E, Lake S, Nolan S, Fairbairn N, Hayashi K, et al. High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis. Addiction. 2018;113:2250–8.
Article
PubMed
PubMed Central
Google Scholar
Nutt DJ, King LA, Phillips LD. Drug harms in the UK: a multicriteria decision analysis. Lancet. 2010;376:1558–65.
Article
PubMed
Google Scholar
The Constitutional Court of South Africa. Minister of justice and constitutional development and others v prince (Clarke, Stobbs and Thorpe Intervening) (Doctors of Life International Inc as Amicus Curiae); National Director of Public Prosecutions and Others v Rubin; National Director of Public P. 2018. https://hdl.handle.net/20.500.12144/34547.
Dada S, Harker N, Jodilee B, Warren E, Parry C, Bhana A, et al. April 2019 Phase 44. Cape Town: SA Medical Research Council; 2019.
Google Scholar
UNODC, UNWOMEN, WHO, INPUD. Women who inject drugs and HIV: addressing specific needs issue summary: the key reasons and unique challenges. Policy brief. 2014.
Dannatt L, Cloete KJ, Kidd M, Weich L. Frequency and correlates of comorbid psychiatric illness in patients with heroin use disorder admitted to Stikland Opioid Detoxification Unit, South Africa. S Afr J Psychiatry. 2014;20:77.
Article
Google Scholar
Morgan N, Daniels W, Subramaney U. A prospective observational study of heroin users in Johannesburg, South Africa: assessing psychiatric comorbidities and treatment outcomes. Compr Psychiatry. 2019. https://doi.org/10.1016/j.comppsych.2019.152137.
Article
PubMed
Google Scholar